Anebulo Pharmaceuticals, Inc.

NasdaqCM:ANEB Stock Report

Market Cap: US$36.3m

Anebulo Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Richie Cunningham

Chief executive officer

US$1.8m

Total compensation

CEO salary percentage18.3%
CEO tenure1.1yrs
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Jun 22
Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?

Feb 18
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Deliver On Growth Plans?

Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?

Jul 03
Is Anebulo Pharmaceuticals (NASDAQ:ANEB) In A Good Position To Invest In Growth?

Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Mar 07
Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth

Nov 19
We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Can Afford To Drive Business Growth

Anebulo Pharmaceuticals to launch private investment in public equity financing

Sep 26

Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03

Sep 09

Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Jun 28
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Mar 15
Companies Like Anebulo Pharmaceuticals (NASDAQ:ANEB) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Nov 04
Here's Why We're Not Too Worried About Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation

Anebulo Pharmaceuticals reports FQ3 results

Jun 21

CEO Compensation Analysis

How has Richie Cunningham's remuneration changed compared to Anebulo Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$8m

Jun 30 2024US$2mUS$333k

-US$8m

Compensation vs Market: Richie's total compensation ($USD1.82M) is above average for companies of similar size in the US market ($USD646.00K).

Compensation vs Earnings: Insufficient data to compare Richie's compensation with company performance.


CEO

Richie Cunningham (53 yo)

1.1yrs

Tenure

US$1,819,383

Compensation

Mr. Richard Anthony Cunningham, also known as Richie, is Chief Executive Officer and Director of Anebulo Pharmaceuticals, Inc. since October 2023. He served as Chief Executive Officer and Director at Tyme...


Leadership Team

NamePositionTenureCompensationOwnership
Joseph Lawler
Founder & Chairman4.6yrsUS$83.11k46.27%
$ 16.8m
Richard Cunningham
CEO & Director1.1yrsUS$1.82mno data
Daniel George
Principal Accounting Officer1.2yrsUS$194.25kno data
Kenneth Cundy
Chief Scientific Officer2.5yrsUS$612.15k0%
$ 0

1.8yrs

Average Tenure

53.5yo

Average Age

Experienced Management: ANEB's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Joseph Lawler
Founder & Chairman4.6yrsUS$83.11k46.27%
$ 16.8m
Richard Cunningham
CEO & Director1.1yrsUS$1.82mno data
Bimal Shah
Independent Director1.1yrsUS$124.53k0%
$ 0
Kenneth Lin
Lead Independent Director3.8yrsUS$68.24k0%
$ 0
Areta Kupchyk
Independent Director3.6yrsUS$76.87k0%
$ 0
Jason Aryeh
Independent Director3.7yrsUS$83.24k0%
$ 0
Nathaniel Calloway
Independent Director2.1yrsUS$67.26k0%
$ 0
Aron English
Independent Director4.4yrsUS$66.87k17.95%
$ 6.5m
Andrew Monte
Member of Scientific Advisory Board3.8yrsno datano data
Arjun Chanmugam
Member of Scientific Advisory Board3.8yrsno datano data

3.7yrs

Average Tenure

52yo

Average Age

Experienced Board: ANEB's board of directors are considered experienced (3.7 years average tenure).